ANVISA will implement new rules for medical device modifications in Brazil

Brazil – ANVISA announces major medical device registration updates

Brazil’s medical device market regulator, ANVISA announced major updates to its Resolution of the Collegiate Board of Directors (RDC) 185/2001. The changes will serve...
Topical Drug Products for Cutaneous Application: Human Safety Assessment Guidance

USA – FDA issues roadmap to medical device regulatory guidance topics list for 2023

The US Food and Drug Administration has released a list of guidance documents it plans to issue over its 2023 fiscal year. FDA’s Center...

Canada – Amendments to the Medical Devices Regulations to address future public health emergencies

On February 22, 2023, the Regulations Amending the Medical Devices Regulations (Interim Order No. 3 Respecting the Importation and Sale of Medical Devices for Use...

USA – Advocacy groups, AdvaMed vie for next phase of TAP pilot

Medical devices that treat brain diseases and disorders should be the next products to be accepted into a US Food and Drug Administration (FDA)...

USA – FDA updates guidance on identifying and responding to deficiencies

The US Food and Drug Administration has revised the guidance document Developing and Responding to Deficiencies in Accordance with the Least Burdensome Provisions to update the...

Canada – Notice on Health Canada’s proposed changes to the guidance on recognized standards...

About the updates Health Canada has updated the: List of recognized standards for medical devices and Guidance on using standards to support compliance with the Medical...

USA – FDA advisors want standards, labeling to address racial disparities with pulse oximeters

A panel of external US Food and Drug Administration (FDA) experts are urging more research to improve the efficacy of pulse oximeters in people...

USA – FDA issues draft guidance on decentralized clinical trials

In a newly released draft guidance, the US Food and Drug Administration (FDA) is proposing recommendations on conducting decentralized clinical trials (DCTs) of drugs,...

USA – FDA revamps device software premarket submissions guidance

The US Food and Drug Administration (FDA) this week finalized guidance on the content of premarket submission for software functions in medical devices. The...

USA – FDA guidance proposes devices be deemed adulterated for refusing inspections

The US Food and Drug Administration’s (FDA) has issued draft guidance proposing that devices be deemed adulterated and refused entry to the US market...

NOS PROCHAINES FORMATIONS